TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Kallyope Stock

Kallyope Stock

kallyope.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $479.46MM

Kallyope is a platform biotechnology company dedicated to unlocking the therapeutic potential of the gut-brain axis by integrating cutting-edge technologies in sequencing, computational biology, neural imaging, cellular and molecular biology, and human genetics to provide an understanding of gut-brain biology that will lead to transformational therapeutics that improve human health.

Buy or sell Kallyope stockLearn more about Kallyope IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Kallyope, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Kallyope’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Kallyope.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Juha Lauren Ph.D
Chief Business Officer
Maximilian Lombardo
Senior Data Research Associate
Tom Maniatis Ph.D
Co-Founder & Board Member
Charles Zuker Ph.D
Co-Founder
Ann Weber Ph.D
Senior Vice President - Drug Discovery
Brett Lauring
Chief Medical Officer
Nancy Thornberry
Chief Executive Officer & Board Member
Richard Axel MD
Co-Founder
Robert Anstey
Vice President, Business Development

Board Members

Joshua Wolfe
Lux Capital Management
Tony Evnin Ph.D
Amy Schulman JD
Polaris Partners
Timothy Kutzkey Ph.D
The Column Group
William Rieflin JD
Nancy Thornberry
Terry McGuire
Tom Maniatis Ph.D

Frequently Asked Questions About Kallyope’s Stock

plusminus
Can you buy Kallyope’s stock?
Kallyope is not publicly traded on NYSE or NASDAQ in the U.S. To buy Kallyope’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Kallyope’s stock?
Yes, you can sell stock of a private company like Kallyope. Forge can help you sell your Kallyope stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Kallyope’s stock price?
Kallyope is a privately held company and therefore does not have a public stock price. However, you may access Kallyope’s private market stock price with Forge Data.
plusminus
What is Kallyope’s stock ticker symbol?
Kallyope does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Kallyope in the BioTech & Pharma sector

Egenesis

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$387.57MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Precision Neuroscience

Sector
Healthcare / BioTech & Pharma
 
 

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

BioAge

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$439.94MM

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM

Life Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$500MM

Cytonics

Sector
Healthcare / BioTech & Pharma
 
 

News Highlights

FinSMEs 12/05/2018
Kallyope Raises $21M Expansion of Series B Financing | FinSMEs
Kallyope, a biotech company focused on identifying therapeutic opportunities involving the gut-brain axis, raised $21m in Series B financing

Trending Companies

Frequently Asked Questions

Updated on: Apr 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.